Literature DB >> 23998027

A cross sectional study of oral submucous fibrosis in central India and the effect of local triamcinolone therapy.

N T Ameer1, Rakesh Kumar Shukla.   

Abstract

The use of processed arecanut is on the increase. In the impending danger of increased occurrence of oral submucous fibrosis and subsequent oral cancer following this habit is colossal. So an attempt is made to clinically evaluate the condition and to evaluate the effect of triamcinolone on this condition. Using the clinical data collected from the patients presenting in the ENT OPD of NSCB Medical College Hospital, Jabalpur, a cross sectional study was done and the effect of intralesional triamcinolone on this condition is noted by biweekly submucosal injections of 40 mg triamcinolone for 12 weeks and followed up for 1 year. The effect of therapy was evaluated subjectively by improvement in symptoms and objectively by increase in mouth opening. The age of occurrence and sex predilection also showed a significant change with more young males being affected by the condition. There was no significant correlation between effect of triamcinolone therapy and duration of addiction but a significant correlation (P < 0.0001) was noted with the frequency of addiction per day. A significant improvement in mouth opening is observed following local triamcinolone therapy. The results imply that the exposure and the frequency of chewing habits, and not mere the duration that is significant in producing the condition and affecting the treatment outcome. Local triamcinolone therapy has good effect in the initial stages of the disease. The fact that more youngsters are being affected needs serious consideration.

Entities:  

Keywords:  Arecanut; Gutkha; Oral submucous fibrosis; Tobacco; Triamcinolone; Trismus

Year:  2011        PMID: 23998027      PMCID: PMC3431518          DOI: 10.1007/s12070-011-0365-9

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  8 in total

1.  Submucous fibrosis of the palate and cheek.

Authors:  J V DESA
Journal:  Ann Otol Rhinol Laryngol       Date:  1957-12       Impact factor: 1.547

2.  Management of oral submucous fibrosis: a conservative approach.

Authors:  R M Borle; S R Borle
Journal:  J Oral Maxillofac Surg       Date:  1991-08       Impact factor: 1.895

Review 3.  Oral submucosal fibrosis--a preventable disease.

Authors:  V Jayanthi; C S Probert; K S Sher; J F Mayberry
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

4.  Malignant transformation rate in oral submucous fibrosis over a 17-year period.

Authors:  P R Murti; R B Bhonsle; J J Pindborg; D K Daftary; P C Gupta; F S Mehta
Journal:  Community Dent Oral Epidemiol       Date:  1985-12       Impact factor: 3.383

5.  Altered staining reaction of connective tissues in 53 submucous fibrosis patients.

Authors:  J E Hamner; F S Mehta; J J Pindborg; D K Daftary
Journal:  J Dent Res       Date:  1971 Mar-Apr       Impact factor: 6.116

Review 6.  Pathogenesis of oral submucous fibrosis. Relationship to risk factors associated with oral cancer.

Authors:  R Pillai; P Balaram; K S Reddiar
Journal:  Cancer       Date:  1992-04-15       Impact factor: 6.860

7.  Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan.

Authors:  R Maher; A J Lee; K A Warnakulasuriya; J A Lewis; N W Johnson
Journal:  J Oral Pathol Med       Date:  1994-02       Impact factor: 4.253

8.  Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids.

Authors:  W Harvey; A Scutt; S Meghji; J P Canniff
Journal:  Arch Oral Biol       Date:  1986       Impact factor: 2.633

  8 in total
  1 in total

1.  Evaluation of Efficacy of Curcumin along with Lycopene and Piperine in the Management of Oral Submucous Fibrosis.

Authors:  Basudev Mahato; Chandraday Prodhan; Samir Mandal; Avirup Dutta; Parna Kumar; Tushar Deb; Tarun Jha; Keya Chaudhuri
Journal:  Contemp Clin Dent       Date:  2019 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.